Duncker Streett & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,500	Closed	-$25K	–	562
2020 Q1	$25K	Hold	6,500	–	–	0.01%	375
2019 Q4	$33K	Buy	+6,500	New	+$33K	0.01%	386
2019 Q3	–	Sell	-7,500	Closed	-$46K	–	550
2019 Q2	$46K	Sell	7,500 -5,118	-41%	-$31.4K	0.01%	370
2019 Q1	$59K	Hold	12,618	–	–	0.01%	359
2018 Q4	$53K	Sell	12,618 -3,100	-20%	-$13K	0.01%	355
2018 Q3	$99K	Hold	15,718	–	–	0.02%	321
2018 Q2	$126K	Hold	15,718	–	–	0.03%	289
2018 Q1	$117K	Buy	15,718 +1,000	+7%	+$7.44K	0.03%	297
2017 Q4	$88K	Hold	14,718	–	–	0.02%	344
2017 Q3	$108K	Hold	14,718	–	–	0.03%	301
2017 Q2	$100K	Hold	14,718	–	–	0.03%	314
2017 Q1	$139K	Hold	14,718	–	–	0.04%	278
2016 Q4	$127K	Hold	14,718	–	–	0.04%	278
2016 Q3	$93K	Sell	14,718 -2,000	-12%	-$12.6K	0.03%	302
2016 Q2	$71K	Hold	16,718	–	–	0.03%	317
2016 Q1	$73K	Sell	16,718 -2,000	-11%	-$8.73K	0.03%	317
2015 Q4	$115K	Sell	18,718 -5,000	-21%	-$30.7K	0.04%	277
2015 Q3	$136K	Sell	23,718 -1,500	-6%	-$8.6K	0.05%	271
2015 Q2	$188K	Hold	25,218	–	–	0.07%	249
2015 Q1	$151K	Hold	25,218	–	–	0.05%	266
2014 Q4	$191K	Hold	25,218	–	–	0.06%	247
2014 Q3	$131K	Sell	25,218 -6,500	-20%	-$33.8K	0.04%	285
2014 Q2	$137K	Buy	31,718 +7,193	+29%	+$31.1K	0.04%	293
2014 Q1	$100K	Hold	24,525	–	–	0.04%	308
2013 Q4	$131K	Hold	24,525	–	–	0.05%	280
2013 Q3	$123K	Hold	24,525	–	–	0.05%	273
2013 Q2	$109K	Buy	+24,525	New	+$109K	0.04%	283